Last 12 months
Inside the activity.
0 purchase rows · 279 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 31 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 111 |
| Feb 2026 | 0 | 11 |
| Mar 2026 | 0 | 106 |
| Apr 2026 | 0 | 14 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 06, 2019 Filed Aug 7, 2019 20:17 UTC |
Vaishnaw AkshayPresident, R&D
|
GrantPerformance Stock Option 2016 (right to buy) · Derivative | 6,250 | $0.00 Strike: $42.22 | $0.00 |
DisclosureSEC source: 0001735276-19-000085 · edgardoc.xml · derivative · entry 4 Vaishnaw Akshay · CIK 0001458494 · President, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 6,250 shares Expires 2026-12-20 F3 · kind: On December 20, 2016, the reporting person was granted a performance based stock option to purchase shares of ALNY common stock. One quarter of the shares subject to the option vested upon the achievement of each of four specific clinical development, regulatory or commercial events, as approved by our compensation committee. The compensation committee of the Company determined that the fourth performance criterion was met effective as of August 6, 2019 and the option vested as to the final one-quarter of the shares as of such date. Read SEC document |
| August 06, 2019 Filed Aug 7, 2019 20:17 UTC |
Vaishnaw AkshayPresident, R&D
|
GrantPerformance Stock Option 2015 (right to buy) · Derivative | 7,500 | $0.00 Strike: $88.95 | $0.00 |
DisclosureSEC source: 0001735276-19-000085 · edgardoc.xml · derivative · entry 3 Vaishnaw Akshay · CIK 0001458494 · President, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 7,500 shares Expires 2025-12-18 F2 · kind: On December 18, 2015, the reporting person was granted a performance based stock option to purchase shares of ALNY common stock. One quarter of the shares subject to the option vested upon the achievement of each of four specific clinical development or commercial events, as approved by our compensation committee. The compensation committee of the Company determined that the fourth performance criterion was met effective as of August 6, 2019 and the option vested as to the final one-quarter of the shares as of such date. Read SEC document |
| August 06, 2019 Filed Aug 7, 2019 20:16 UTC |
Greene Barry EPresident
|
GrantPerformance Stock Option 2016 (right to buy) · Derivative | 6,250 | $0.00 Strike: $42.22 | $0.00 |
DisclosureSEC source: 0001735276-19-000084 · edgardoc.xml · derivative · entry 5 Greene Barry E · CIK 0001291963 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 6,250 shares Expires 2026-12-20 F4 · kind: On December 20, 2016, the reporting person was granted a performance based stock option to purchase shares of ALNY common stock. One quarter of the shares subject to the option vested upon the achievement of each of four specific clinical development, regulatory or commercial events, as approved by our compensation committee. The compensation committee of the Company determined that the fourth performance criterion was met effective as of August 6, 2019 and the option vested as to the final one-quarter of the shares as of such date. Read SEC document |
| August 06, 2019 Filed Aug 7, 2019 20:16 UTC |
Greene Barry EPresident
|
GrantPerformance Stock Option 2015 (right to buy) · Derivative | 10,000 | $88.95 Strike: $88.95 | $889,500.00 |
DisclosureSEC source: 0001735276-19-000084 · edgardoc.xml · derivative · entry 4 Greene Barry E · CIK 0001291963 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 10,000 shares Expires 2025-12-18 F3 · kind: On December 18, 2015, the reporting person was granted a performance based stock option to purchase shares of ALNY common stock. One quarter of the shares subject to the option vested upon the achievement of each of four specific clinical development or commercial events, as approved by our compensation committee. The compensation committee of the Company determined that the fourth performance criterion was met effective as of August 6, 2019 and the option vested as to the final one-quarter of the shares as of such date. Read SEC document |
| August 06, 2019 Filed Aug 7, 2019 20:16 UTC |
MARAGANORE JOHNDirector · Chief Executive Officer
|
GrantPerformance Stock Option 2016 (right to buy) · Derivative | 6,250 | $0.00 Strike: $42.22 | $0.00 |
DisclosureSEC source: 0001735276-19-000083 · edgardoc.xml · derivative · entry 4 MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 6,250 shares Expires 2026-12-20 F3 · kind: On December 20, 2016, the reporting person was granted a performance based stock option to purchase shares of ALNY common stock. One quarter of the shares subject to the option vested upon the achievement of each of four specific clinical development, regulatory or commercial events, as approved by our compensation committee. The compensation committee of the Company determined that the fourth performance criterion was met effective as of August 6, 2019 and the option vested as to the final one-quarter of the shares as of such date. Read SEC document |
| August 06, 2019 Filed Aug 7, 2019 20:16 UTC |
MARAGANORE JOHNDirector · Chief Executive Officer
|
GrantPerformance Stock Option 2015 (right to buy) · Derivative | 16,250 | $0.00 Strike: $88.95 | $0.00 |
DisclosureSEC source: 0001735276-19-000083 · edgardoc.xml · derivative · entry 3 MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 16,250 shares Expires 2025-12-18 F2 · kind: On December 18, 2015, the reporting person was granted a performance based stock option to purchase shares of ALNY common stock. One quarter of the shares subject to the option vested upon the achievement of each of four specific clinical development or commercial events, as approved by our compensation committee. The compensation committee of the Company determined that the fourth performance criterion was met effective as of August 6, 2019 and the option vested as to the final one-quarter of the shares as of such date. Read SEC document |
| July 11, 2019 Filed Aug 7, 2019 20:17 UTC |
Greenstreet YvonneChief Operating Officer
|
OtherCommon Stock | 50 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-19-000087 · edgardoc.xml · nonDerivative · entry 1 Greenstreet Yvonne · CIK 0001446125 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Managed Account Disclosed balance after: 407 F1 · kind: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. F1 · price: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. F1 · ownership.nature: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. Read SEC document |
| July 11, 2019 Filed Aug 7, 2019 20:17 UTC |
KEATING LAURIEEVP, Chief Legal Officer
|
OtherCommon Stock | 49 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-19-000086 · edgardoc.xml · nonDerivative · entry 1 KEATING LAURIE · CIK 0001620743 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Managed Account Disclosed balance after: 424 F1 · kind: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. F1 · price: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. F1 · ownership.nature: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. Read SEC document |
| July 11, 2019 Filed Aug 7, 2019 20:17 UTC |
Vaishnaw AkshayPresident, R&D
|
OtherCommon Stock | 48 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-19-000085 · edgardoc.xml · nonDerivative · entry 1 Vaishnaw Akshay · CIK 0001458494 · President, R&D 10b5-1 filing: Not disclosed Ownership: Indirect · by Managed Account Disclosed balance after: 515 F1 · kind: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. F1 · price: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. F1 · ownership.nature: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. Read SEC document |
| July 11, 2019 Filed Aug 7, 2019 20:16 UTC |
Greene Barry EPresident
|
OtherCommon Stock | 46 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-19-000084 · edgardoc.xml · nonDerivative · entry 1 Greene Barry E · CIK 0001291963 · President 10b5-1 filing: Not disclosed Ownership: Indirect · by Managed Account Disclosed balance after: 3,003 F1 · kind: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. F1 · price: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. F1 · ownership.nature: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. Read SEC document |
| July 11, 2019 Filed Aug 7, 2019 20:16 UTC |
MARAGANORE JOHNDirector · Chief Executive Officer
|
OtherCommon Stock | 34 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-19-000083 · edgardoc.xml · nonDerivative · entry 1 MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Managed Account Disclosed balance after: 3,133 F1 · kind: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. F1 · price: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. F1 · ownership.nature: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:06 UTC |
PYOTT DAVID E IDirector
|
GrantStock Option (right to buy) · Derivative | 9,000 | $0.00 Strike: $72.01 | $0.00 |
DisclosureSEC source: 0001735276-19-000063 · edgardoc.xml · derivative · entry 1 PYOTT DAVID E I · CIK 0001051578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2029-06-30 Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:06 UTC |
SCHIMMEL PAULDirector
|
GrantStock Option (right to buy) · Derivative | 9,000 | $0.00 Strike: $72.01 | $0.00 |
DisclosureSEC source: 0001735276-19-000065 · edgardoc.xml · derivative · entry 1 SCHIMMEL PAUL · CIK 0001236447 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2029-06-30 Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:05 UTC |
HAMBURG MARGARET ADirector
|
GrantStock Option (right to buy) · Derivative | 9,000 | $0.00 Strike: $72.01 | $0.00 |
DisclosureSEC source: 0001735276-19-000061 · edgardoc.xml · derivative · entry 1 HAMBURG MARGARET A · CIK 0001266917 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2029-06-30 Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:05 UTC |
Fanucci MarshaDirector
|
GrantStock Option (right to buy) · Derivative | 9,000 | $0.00 Strike: $72.01 | $0.00 |
DisclosureSEC source: 0001735276-19-000060 · edgardoc.xml · derivative · entry 1 Fanucci Marsha · CIK 0001298814 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2029-06-30 Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:07 UTC |
SHARP PHILLIP ADirector
|
GrantStock Option (right to buy) · Derivative | 9,000 | $0.00 Strike: $72.01 | $0.00 |
DisclosureSEC source: 0001735276-19-000067 · edgardoc.xml · derivative · entry 1 SHARP PHILIP A · CIK 0001226295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2029-06-30 Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:07 UTC |
BONNEY MICHAEL WDirector
|
GrantStock Option (right to buy) · Derivative | 9,000 | $0.00 Strike: $72.01 | $0.00 |
DisclosureSEC source: 0001735276-19-000068 · edgardoc.xml · derivative · entry 1 BONNEY MICHAEL W · CIK 0001219016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2029-06-30 Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:07 UTC |
SCHULMAN AMY WDirector
|
GrantStock Option (right to buy) · Derivative | 9,000 | $0.00 Strike: $72.01 | $0.00 |
DisclosureSEC source: 0001735276-19-000066 · edgardoc.xml · derivative · entry 1 SCHULMAN AMY W · CIK 0001438226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2029-06-30 Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:06 UTC |
Reitan Colleen FDirector
|
GrantStock Option (right to buy) · Derivative | 9,000 | $0.00 Strike: $72.01 | $0.00 |
DisclosureSEC source: 0001735276-19-000064 · edgardoc.xml · derivative · entry 1 Reitan Colleen F · CIK 0001740730 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2029-06-30 Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:05 UTC |
PAUL STEVEN MDirector
|
GrantStock Option (right to buy) · Derivative | 9,000 | $0.00 Strike: $72.01 | $0.00 |
DisclosureSEC source: 0001735276-19-000062 · edgardoc.xml · derivative · entry 1 PAUL STEVEN M · CIK 0001237564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2029-06-30 Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:03 UTC |
Ausiello Dennis ADirector
|
GrantStock Option (right to buy) · Derivative | 9,000 | $0.00 Strike: $72.01 | $0.00 |
DisclosureSEC source: 0001735276-19-000059 · edgardoc.xml · derivative · entry 1 Ausiello Dennis A · CIK 0001381994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2029-06-30 Read SEC document |
| June 05, 2019 Filed Jun 7, 2019 20:04 UTC |
Greene Barry EPresident
|
GrantPerformance Stock Option 2016 (right to buy) · Derivative | 6,250 | $0.00 Strike: $42.22 | $0.00 |
DisclosureSEC source: 0001735276-19-000046 · edgardoc.xml · derivative · entry 5 Greene Barry E · CIK 0001291963 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,750 Underlying: Common Stock · 6,250 shares Expires 2026-12-20 F3 · kind: On December 20, 2016, the reporting person was granted a performance based stock option to purchase shares of ALNY common stock. One quarter of the shares subject to the option will vest upon the achievement of each of four specific clinical development, regulatory or commercial events, as approved by our compensation committee. On June 6, 2019, the compensation committee of the Company determined the third performance criterion had been met on June 5, 2019 and the option vested as to one-quarter of the shares as of such date. Read SEC document |
| June 05, 2019 Filed Jun 7, 2019 20:04 UTC |
MARAGANORE JOHNDirector · Chief Executive Officer
|
GrantPerformance Stock Option 2016 (right to buy) · Derivative | 6,250 | $0.00 Strike: $42.22 | $0.00 |
DisclosureSEC source: 0001735276-19-000048 · edgardoc.xml · derivative · entry 1 MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,750 Underlying: Common Stock · 6,250 shares Expires 2026-12-20 F1 · kind: On December 20, 2016, the reporting person was granted a performance based stock option to purchase shares of ALNY common stock. One quarter of the shares subject to the option will vest upon the achievement of each of four specific clinical development, regulatory or commercial events, as approved by our compensation committee. On June 6, 2019, the compensation committee of the Company determined the third performance criterion had been met on June 5, 2019 and the option vested as to one-quarter of the shares as of such date. Read SEC document |
| June 05, 2019 Filed Jun 7, 2019 20:04 UTC |
Greenstreet YvonneChief Operating Officer
|
GrantPerformance Stock Option 2016 (right to buy) · Derivative | 6,250 | $0.00 Strike: $42.22 | $0.00 |
DisclosureSEC source: 0001735276-19-000047 · edgardoc.xml · derivative · entry 3 Greenstreet Yvonne · CIK 0001446125 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,750 Underlying: Common Stock · 6,250 shares Expires 2026-12-20 F2 · kind: On December 20, 2016, the reporting person was granted a performance based stock option to purchase shares of ALNY common stock. One quarter of the shares subject to the option will vest upon the achievement of each of four specific clinical development, regulatory or commercial events, as approved by our compensation committee. On June 6, 2019, the compensation committee of the Company determined the third performance criterion had been met on June 5, 2019 and the option vested as to one-quarter of the shares as of such date. Read SEC document |
| June 05, 2019 Filed Jun 7, 2019 20:03 UTC |
Vaishnaw AkshayPresident, R&D
|
GrantPerformance Stock Option 2016 (right to buy) · Derivative | 6,250 | $0.00 Strike: $42.22 | $0.00 |
DisclosureSEC source: 0001735276-19-000045 · edgardoc.xml · derivative · entry 4 Vaishnaw Akshay · CIK 0001458494 · President, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,750 Underlying: Common Stock · 6,250 shares Expires 2026-12-20 F2 · kind: On December 20, 2016, the reporting person was granted a performance based stock option to purchase shares of ALNY common stock. One quarter of the shares subject to the option will vest upon the achievement of each of four specific clinical development, regulatory or commercial events, as approved by our compensation committee. On June 6, 2019, the compensation committee of the Company determined the third performance criterion had been met on June 5, 2019 and the option vested as to one-quarter of the shares as of such date. Read SEC document |
| June 05, 2019 Filed Jun 7, 2019 20:03 UTC |
KEATING LAURIEEVP, Chief Legal Officer
|
GrantPerformance Stock Option 2016 (right to buy) · Derivative | 6,250 | $0.00 Strike: $42.22 | $0.00 |
DisclosureSEC source: 0001735276-19-000044 · edgardoc.xml · derivative · entry 4 KEATING LAURIE · CIK 0001620743 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,750 Underlying: Common Stock · 6,250 shares Expires 2026-12-20 F2 · kind: On December 20, 2016, the reporting person was granted a performance based stock option to purchase shares of ALNY common stock. One quarter of the shares subject to the option will vest upon the achievement of each of four specific clinical development, regulatory or commercial events, as approved by our compensation committee. On June 6, 2019, the compensation committee of the Company determined the third performance criterion had been met on June 5, 2019 and the option vested as to one-quarter of the shares as of such date. Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:07 UTC |
MARAGANORE JOHNDirector · Chief Executive Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 49,457 | $0.00 Strike: $16.43 | $0.00 |
DisclosureSEC source: 0001553878-19-000002 · edgardoc.xml · derivative · entry 4 MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,456 Underlying: Common Stock · 49,457 shares Expires 2019-12-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 11, 2019. The 49,457 options exercised and sold by the reporting person were due to expire on December 10, 2019. F3 · derivative.exercise_date: The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:07 UTC |
MARAGANORE JOHNDirector · Chief Executive Officer
|
SaleCommon Stock | 49,457 | $70.00 | $3,461,990.00 |
DisclosureSEC source: 0001553878-19-000002 · edgardoc.xml · nonDerivative · entry 2 MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,993 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 11, 2019. The 49,457 options exercised and sold by the reporting person were due to expire on December 10, 2019. Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:07 UTC |
MARAGANORE JOHNDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 49,457 | $16.43 | $812,578.51 |
DisclosureSEC source: 0001553878-19-000002 · edgardoc.xml · nonDerivative · entry 1 MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,450 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 11, 2019. The 49,457 options exercised and sold by the reporting person were due to expire on December 10, 2019. Read SEC document |
| April 15, 2019 Filed Apr 17, 2019 20:05 UTC |
SHARP PHILLIP ADirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $22.09 | $0.00 |
DisclosureSEC source: 0001735276-19-000037 · edgardoc.xml · derivative · entry 7 SHARP PHILIP A · CIK 0001226295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2019-06-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2018. Read SEC document |
| April 15, 2019 Filed Apr 17, 2019 20:05 UTC |
SHARP PHILLIP ADirector
|
SaleCommon Stock | 600 | $91.40 | $54,840.00 |
DisclosureSEC source: 0001735276-19-000037 · edgardoc.xml · nonDerivative · entry 5 SHARP PHILIP A · CIK 0001226295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,633 F1 · kind: The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2018. F5 · price: Sale prices ranged from $91.00 to $91.86. Read SEC document |
| April 15, 2019 Filed Apr 17, 2019 20:05 UTC |
SHARP PHILLIP ADirector
|
SaleCommon Stock | 400 | $89.97 | $35,988.00 |
DisclosureSEC source: 0001735276-19-000037 · edgardoc.xml · nonDerivative · entry 4 SHARP PHILIP A · CIK 0001226295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,233 F1 · kind: The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2018. F4 · price: Sale prices ranged from $89.56 to $90.13. Read SEC document |
| April 15, 2019 Filed Apr 17, 2019 20:05 UTC |
SHARP PHILLIP ADirector
|
SaleCommon Stock | 2,200 | $89.03 | $195,866.00 |
DisclosureSEC source: 0001735276-19-000037 · edgardoc.xml · nonDerivative · entry 3 SHARP PHILIP A · CIK 0001226295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,633 F1 · kind: The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2018. F3 · price: Sale prices ranged from $88.49 to $89.43. Read SEC document |
| April 15, 2019 Filed Apr 17, 2019 20:05 UTC |
SHARP PHILLIP ADirector
|
SaleCommon Stock | 11,800 | $87.86 | $1,036,748.00 |
DisclosureSEC source: 0001735276-19-000037 · edgardoc.xml · nonDerivative · entry 2 SHARP PHILIP A · CIK 0001226295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,833 F1 · kind: The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2018. F2 · price: Sale prices ranged from $87.48 to $88.43. Read SEC document |
| April 15, 2019 Filed Apr 17, 2019 20:05 UTC |
SHARP PHILLIP ADirector
|
Exercise / conversionCommon Stock | 15,000 | $22.09 | $331,350.00 |
DisclosureSEC source: 0001735276-19-000037 · edgardoc.xml · nonDerivative · entry 1 SHARP PHILIP A · CIK 0001226295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,633 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2018. Read SEC document |
| April 09, 2019 Filed May 17, 2019 20:07 UTC |
MARAGANORE JOHNDirector · Chief Executive Officer
|
OtherCommon Stock | 61 | $0.00 | $0.00 |
DisclosureSEC source: 0001553878-19-000002 · edgardoc.xml · nonDerivative · entry 3 MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Managed Account Disclosed balance after: 3,099 F2 · kind: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. F2 · price: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. F2 · ownership.nature: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. Read SEC document |
| April 09, 2019 Filed Jun 7, 2019 20:04 UTC |
Greene Barry EPresident
|
OtherCommon Stock | 52 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-19-000046 · edgardoc.xml · nonDerivative · entry 2 Greene Barry E · CIK 0001291963 · President 10b5-1 filing: Not disclosed Ownership: Indirect · by Managed Account Disclosed balance after: 2,957 F1 · kind: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. F1 · price: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. F1 · ownership.nature: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. Read SEC document |
| April 09, 2019 Filed Jun 7, 2019 20:04 UTC |
Greenstreet YvonneChief Operating Officer
|
OtherCommon Stock | 49 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-19-000047 · edgardoc.xml · nonDerivative · entry 1 Greenstreet Yvonne · CIK 0001446125 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Managed Account Disclosed balance after: 357 F1 · kind: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. F1 · price: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. F1 · ownership.nature: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. Read SEC document |
| April 09, 2019 Filed Jun 7, 2019 20:03 UTC |
Vaishnaw AkshayPresident, R&D
|
OtherCommon Stock | 51 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-19-000045 · edgardoc.xml · nonDerivative · entry 2 Vaishnaw Akshay · CIK 0001458494 · President, R&D 10b5-1 filing: Not disclosed Ownership: Indirect · by Managed Account Disclosed balance after: 467 F1 · kind: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. F1 · price: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. F1 · ownership.nature: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. Read SEC document |
| April 09, 2019 Filed Jun 7, 2019 20:03 UTC |
KEATING LAURIEEVP, Chief Legal Officer
|
OtherCommon Stock | 41 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-19-000044 · edgardoc.xml · nonDerivative · entry 2 KEATING LAURIE · CIK 0001620743 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Managed Account Disclosed balance after: 375 F1 · kind: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. F1 · price: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. F1 · ownership.nature: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 23:11 UTC |
Greenstreet YvonneEVP, Chief Operating Officer
|
GrantStock Option (right to buy) · Derivative | 32,500 | $0.00 Strike: $85.00 | $0.00 |
DisclosureSEC source: 0001735276-19-000035 · edgardoc.xml · derivative · entry 1 Greenstreet Yvonne · CIK 0001446125 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,500 Underlying: Common Stock · 32,500 shares Expires 2029-02-27 F1 · shares: Represents the time-vested portion of the reporting person's Annual Stock Option Award for 2018. The reporting person also received 16,250 performance stock units that will vest upon the achievement of three specific performance conditions, which will be reported on a Form 4 if and when each performance condition is met and the option vests. F2 · derivative.exercise_date: The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 23:10 UTC |
Greene Barry EPresident
|
GrantStock Option (right to buy) · Derivative | 32,500 | $0.00 Strike: $85.00 | $0.00 |
DisclosureSEC source: 0001735276-19-000034 · edgardoc.xml · derivative · entry 1 Greene Barry E · CIK 0001291963 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,500 Underlying: Common Stock · 32,500 shares Expires 2029-02-27 F1 · shares: Represents the time-vested portion of the reporting person's Annual Stock Option Award for 2018. The reporting person also received 16,250 performance stock units that will vest upon the achievement of three specific performance conditions, which will be reported on a Form 4 if and when each performance condition is met and the option vests. F2 · derivative.exercise_date: The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 23:10 UTC |
Soni Manmeet SinghChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $85.00 | $0.00 |
DisclosureSEC source: 0001735276-19-000033 · edgardoc.xml · derivative · entry 1 Soni Manmeet Singh · CIK 0001569769 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-02-27 F1 · shares: Represents the time-vested portion of the reporting person's Annual Stock Option Award for 2018. The reporting person also received 10,000 performance stock units that will vest upon the achievement of three specific performance conditions, which will be reported on a Form 4 if and when each performance condition is met and the option vests F2 · derivative.exercise_date: The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 23:10 UTC |
Vaishnaw AkshayPresident, R&D
|
GrantStock Option (right to buy) · Derivative | 32,500 | $0.00 Strike: $85.00 | $0.00 |
DisclosureSEC source: 0001735276-19-000032 · edgardoc.xml · derivative · entry 1 Vaishnaw Akshay · CIK 0001458494 · President, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,500 Underlying: Common Stock · 32,500 shares Expires 2029-02-27 F1 · shares: Represents the time-vested portion of the reporting person's Annual Stock Option Award for 2018. The reporting person also received 16,250 performance stock units that will vest upon the achievement of three specific performance conditions, which will be reported on a Form 4 if and when each performance condition is met and the option vests. F2 · derivative.exercise_date: The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 23:09 UTC |
KEATING LAURIESVP, GC & Secretary
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $85.00 | $0.00 |
DisclosureSEC source: 0001735276-19-000031 · edgardoc.xml · derivative · entry 1 KEATING LAURIE · CIK 0001620743 · SVP, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2029-02-27 F1 · shares: Represents the time-vested portion of the reporting person's Annual Stock Option Award for 2018. The reporting person also received 12,500 performance stock units that will vest upon the achievement of three specific performance conditions, which will be reported on a Form 4 if and when each performance condition is met and the option vests. F2 · derivative.exercise_date: The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 23:09 UTC |
MARAGANORE JOHNDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 85,000 | $0.00 Strike: $85.00 | $0.00 |
DisclosureSEC source: 0001735276-19-000030 · edgardoc.xml · derivative · entry 1 MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires 2029-02-27 F1 · shares: Represents the time-vested portion of the reporting person's Annual Stock Option Award for 2018. The reporting person also received 42,500 performance stock units that will vest upon the achievement of three specific performance conditions, which will be reported on a Form 4 if and when each performance condition is met and the option vests. F2 · derivative.exercise_date: The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
| January 10, 2019 Filed Jan 11, 2019 21:07 UTC |
HAMBURG MARGARET ADirector
|
GrantStock Option (right to buy) · Derivative | 18,000 | $0.00 Strike: $89.16 | $0.00 |
DisclosureSEC source: 0001735276-19-000016 · edgardoc.xml · derivative · entry 1 HAMBURG MARGARET A · CIK 0001266917 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2029-01-10 F1 · derivative.exercise_date: The stock option will vest as to one third of the shares on each of the first, second and third anniversaries of the date of grant. Read SEC document |
| November 21, 2018 Filed Nov 26, 2018 21:11 UTC |
MARAGANORE JOHNDirector · Chief Executive Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 98,636 | $0.00 Strike: $21.35 | $0.00 |
DisclosureSEC source: 0001735276-18-000079 · edgardoc.xml · derivative · entry 4 MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 98,636 shares Expires 2018-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents a "net exercise" of outstanding stock options due to expire on December 8, 2018, as permitted under the governing ALNY stock incentive plan. These shares were withheld by ALNY for payment of the option exercise price and applicable tax withholding, based on the closing price of ALNY common stock on November 21, 2018. F3 · derivative.exercise_date: The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
| November 21, 2018 Filed Nov 26, 2018 21:11 UTC |
MARAGANORE JOHNDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 59,940 | $72.68 | $4,356,439.20 |
DisclosureSEC source: 0001735276-18-000079 · edgardoc.xml · nonDerivative · entry 2 MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,993 F1 · kind: Represents a "net exercise" of outstanding stock options due to expire on December 8, 2018, as permitted under the governing ALNY stock incentive plan. These shares were withheld by ALNY for payment of the option exercise price and applicable tax withholding, based on the closing price of ALNY common stock on November 21, 2018. Read SEC document |
| November 21, 2018 Filed Nov 26, 2018 21:11 UTC |
MARAGANORE JOHNDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 98,636 | $21.35 | $2,105,878.60 |
DisclosureSEC source: 0001735276-18-000079 · edgardoc.xml · nonDerivative · entry 1 MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,933 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents a "net exercise" of outstanding stock options due to expire on December 8, 2018, as permitted under the governing ALNY stock incentive plan. These shares were withheld by ALNY for payment of the option exercise price and applicable tax withholding, based on the closing price of ALNY common stock on November 21, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.